Amgen (AMGN) on Watch Amid Unconfirmed Market Chatter

August 18, 2016 10:34 AM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Amgen (NASDAQ: AMGN) was on watch Thursday amid unconfirmed market chatter involving Pfizer (NYSE: PFE).

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Rumors, Trader Talk

Add Your Comment